ZA971260B - Substituted thiophenylalkenlyl carboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them. - Google Patents

Substituted thiophenylalkenlyl carboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.

Info

Publication number
ZA971260B
ZA971260B ZA9701260A ZA971260A ZA971260B ZA 971260 B ZA971260 B ZA 971260B ZA 9701260 A ZA9701260 A ZA 9701260A ZA 971260 A ZA971260 A ZA 971260A ZA 971260 B ZA971260 B ZA 971260B
Authority
ZA
South Africa
Prior art keywords
medicament
thiophenylalkenlyl
diagnostic
substituted
preparation
Prior art date
Application number
ZA9701260A
Other languages
English (en)
Inventor
Jan-Robert Schwark
Joachim Brendel
Heinz-Werner Kleemann
Hans Jochen Lang
Andreas Weichert
Udo Albus
Wolfgang Scholz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA971260B publication Critical patent/ZA971260B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9701260A 1996-02-15 1997-02-14 Substituted thiophenylalkenlyl carboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them. ZA971260B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19605610A DE19605610A1 (de) 1996-02-15 1996-02-15 Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
ZA971260B true ZA971260B (en) 1997-08-15

Family

ID=7785491

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9701260A ZA971260B (en) 1996-02-15 1997-02-14 Substituted thiophenylalkenlyl carboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.

Country Status (29)

Country Link
US (1) US5756535A (tr)
EP (1) EP0790245B1 (tr)
JP (1) JP4402747B2 (tr)
KR (1) KR970061887A (tr)
AR (1) AR005812A1 (tr)
AT (1) ATE202096T1 (tr)
AU (1) AU706554B2 (tr)
BR (1) BR9700990A (tr)
CA (1) CA2197628C (tr)
CZ (1) CZ45597A3 (tr)
DE (2) DE19605610A1 (tr)
DK (1) DK0790245T3 (tr)
ES (1) ES2158383T3 (tr)
GR (1) GR3036122T3 (tr)
HR (1) HRP970081B1 (tr)
HU (1) HUP9700437A3 (tr)
ID (1) ID15889A (tr)
IL (1) IL120214A (tr)
MX (1) MX9701163A (tr)
NO (1) NO315424B1 (tr)
NZ (1) NZ314230A (tr)
PL (1) PL318412A1 (tr)
PT (1) PT790245E (tr)
RU (1) RU2193033C2 (tr)
SI (1) SI0790245T1 (tr)
SK (1) SK282440B6 (tr)
TR (1) TR199700109A2 (tr)
TW (1) TW445261B (tr)
ZA (1) ZA971260B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19634229A1 (de) * 1996-08-23 1998-02-26 Basf Ag Photostabile UV-A-Filter enthaltende kosmetische Zubereitungen
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
WO2000064445A1 (en) 1999-04-23 2000-11-02 Bristol-Myers Squibb Company Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
RO122203B1 (ro) 2001-10-19 2009-02-27 Toyama Chemical Co., Ltd. Derivaţi de alchil eter şi sărurile acestora

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE4402057A1 (de) * 1994-01-25 1995-08-03 Hoechst Ag Perfluoralkylgruppen tragende phenyl-substituierte Alkylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
TW415937B (en) * 1994-01-25 2000-12-21 Hoechst Ag Phenyl-substituted alkylcarboxylic acid guanidides bearing perfluoroalkyl groups, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
IL120214A (en) 2000-08-31
SK21397A3 (en) 1997-09-10
PT790245E (pt) 2001-10-30
US5756535A (en) 1998-05-26
CA2197628A1 (en) 1997-08-16
EP0790245A1 (de) 1997-08-20
CZ45597A3 (en) 1997-09-17
KR970061887A (ko) 1997-09-12
GR3036122T3 (en) 2001-09-28
TW445261B (en) 2001-07-11
HRP970081A2 (en) 1998-04-30
ATE202096T1 (de) 2001-06-15
HU9700437D0 (en) 1997-04-28
IL120214A0 (en) 1997-06-10
JP4402747B2 (ja) 2010-01-20
DE59703746D1 (de) 2001-07-19
AU1265997A (en) 1997-08-21
ID15889A (id) 1997-08-14
EP0790245B1 (de) 2001-06-13
PL318412A1 (en) 1997-08-18
JPH09249660A (ja) 1997-09-22
BR9700990A (pt) 1998-09-01
NO970697D0 (no) 1997-02-14
SK282440B6 (sk) 2002-02-05
HUP9700437A2 (hu) 1998-08-28
RU2193033C2 (ru) 2002-11-20
HRP970081B1 (en) 2003-04-30
AU706554B2 (en) 1999-06-17
ES2158383T3 (es) 2001-09-01
HUP9700437A3 (en) 2000-03-28
SI0790245T1 (en) 2001-08-31
NO970697L (no) 1997-08-18
TR199700109A2 (tr) 1997-09-21
DK0790245T3 (da) 2001-09-03
AR005812A1 (es) 1999-07-14
MX9701163A (es) 1997-08-30
NZ314230A (en) 1997-12-19
DE19605610A1 (de) 1997-08-21
NO315424B1 (no) 2003-09-01
CA2197628C (en) 2006-05-16

Similar Documents

Publication Publication Date Title
ZA977494B (en) Phenyl-substituted alkenylcarboxylic acid guanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
EP0771788A3 (de) Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ZA964035B (en) Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
ZA966313B (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them.
ZA974665B (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
ZA963893B (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament of diagnostic, and medicament containing them.
AU4556096A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
ZA971260B (en) Substituted thiophenylalkenlyl carboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
ZA976735B (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them.
ZA966106B (en) 4-flouroalkyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
ZA974664B (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament oder diagnostic, and medicament containing them.
AU3900895A (en) Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
AU1239097A (en) Substituted diaryldicarboxylic acid diguanidides, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
GR1002048B (en) Phenilacetic acid derivatives, process for the preparation thereof and corresponding use.
AU7180496A (en) Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
ZA974607B (en) Bis-ortho-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them.
AU4224696A (en) Substituted thiophenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
ZA971514B (en) Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
AU7180396A (en) Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
ZA976390B (en) Neuraminic acid derivatives, their preparation and their medical use.